SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL
Company details
- Active NIF/CIF: B42934356
-
-
-
-
Address: PLAZA ALTOZANO, 9 6º B 02001 (ALBACETE)
-
-
Featured products:
More information on SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL
-
VELASCO SOTO SANTOSDesconocidoTermination of employment: 21/02/2023
-
TRILLO MORADO AMADOR.DesconocidoAppointment: 21/02/2023
-
DE TORRES LOPEZ JUAN JOSE.DesconocidoTermination of employment: 21/02/2023
-
CUBELLS GUIMERA JUANDesconocidoTermination of employment: 21/02/2023
-
CUBELLS GUIMERA JUANAdministrador solidarioAppointment: 29/03/2021
-
VELASCO SOTO SANTOSAdministrador solidarioAppointment: 29/03/2021
-
DE TORRES LOPEZ JUAN JOSEAdministrador solidarioAppointment: 29/03/2021
Other information
The CIF of SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL is B42934356 and its business status is active. Its economic activity belongs to the CNAE 4618 - Intermediarios del comercio especializados en la venta de otros productos específicos. Its SIC is -.
SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL has Between 1 and 9 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Albacete. It has a total of 8 registration charges. Its latest announcement in Borme was published on 21/02/2023 and its last deposit of ordinary annual accounts is from the year 2023.
You can check the contact details of SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL such as phone number, address, or website in the Company Data module.
For more information about SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL, you can acquire one of our available financial reports, the Annual Accounts of the company, or check its payment incidents in the RAI delinquency file.
All the financial, business, and legal information we provide about SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL comes from official sources and is updated daily.
Do you want to know more about SERVICIO FARMACEUTICO DE GESTION EN RENTABILIDAD SL??
Find out more about this company by consulting these reports: